Lower radiation doses for HPV-related throat cancer
Part of Cancer, Ear, nose & throat, Infections, Mouth & dental clinical trials.
This trial tests whether we can safely use lower doses of radiation for people with HPV-related throat cancer, while still targeting the areas that need it. The goal is to reduce side effects without lowering the chance of a cure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of throat cancer (oropharynx cancer) that is p16-positive, meaning it's linked to HPV.
- You are at least 18 years old.
- Your cancer stage must be one of these: early stage (T0-4, N0, N1, N3) or, if you have limited lymph node spread (N2), you must have smoked less than 10 pack-years (a pack-year is smoking one pack per day for a year).
- Your cancer has not spread to distant organs (like lungs or liver).
- You have not had chemotherapy or radiation therapy for this specific cancer before.
- You are willing to use effective birth control during treatment and for 6 months after, if you are of childbearing age or sexually active.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a lower dose of radiation to certain neck areas for people with HPV-related oropharyngeal cancer. The goal is to see if reducing radiation can cause fewer side effects while still curing the cancer.
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
This study tests a way to use less radiation for HPV-related throat cancer. Doctors will adjust your treatment based on a simple blood test that tracks cancer DNA, so you may get only the treatment you need.
This trial tests whether using a lower intensity (reduced) chemo-radiation plan can work for some people with HPV-related oropharyngeal (throat) cancer without losing effectiveness. It may help reduce side effects while still controlling the cancer.
This trial tests if giving less radiation along with chemotherapy is safe and effective for people with HPV-positive throat cancer. It aims to reduce side effects while still controlling the cancer.
This trial tests a less intense treatment approach for people with HPV-positive oropharyngeal cancer. It uses surgery first, followed by fewer or lower doses of radiation and chemotherapy, aiming to reduce side effects while keeping treatment effective.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.